The meeting was facilitated by Bangalore Bioinnovation Centre (BBC). Dr. Ashwathnarayan C. N., Dr Kiran Mazumdar-Shaw, delegations from ABLE and its member companies, BBC officials and their startups with the Government of Karnataka dignitaries were present.

ABLE highlighted to seek exemption/ reduced GST rate for lifesaving medicines used in treatment of COVID-19.

ABLE members who participated in the meeting included Mr. G S Krishnan (President, ABLE & Director- External Stakeholder Relations, Novozymes India); Dr Jitendra Kumar (Director, BBC); Dr Taslimarif Saiyed (Director & CEO, C-CAMP); Mr Siddarth Mittal (CEO, Biocon Ltd); Dr. P M Murali (President, ABLE Business Council); Mr. Krishna Mohan Puvvada (Regional President, India & Business Director, Consumer BioSolutions, Novozymes); Mr Subramanian R (Chairman and Founder, Laurus Bio); Mr Ajay Bharadwaj (Chairman, Anthem Biosciences); Dr K K Narayanan (Founder, Kottaram Agro Foods); Mr Manohar B N (CEO, Stempeutics Research); Dr. Kavitha Iyer Rodrigues (Director, Zumutor Biologics); Dr. Murali Ramachandra (CSO, Aurigene Discovery Technologies Ltd.); Dr. Mahesh Bhalgat (COO, Syngene International); Dr Shreehas Tambe (President & Dy. CEO, Biocon Biologicals); Dr. Arun Anand (COO, Immuneel Therapeutics); Mr Shrikumar Suryanarayan (Chairman, Sea6energy & Ex-President, ABLE) and Mr Narayanan Suresh (COO, ABLE).

ABLE Delegation Meets Key Union Minister